The China Mail - US abortion ruling threatens access to arthritis drug

USD -
AED 3.672975
AFN 71.502412
ALL 86.604424
AMD 389.28007
ANG 1.80229
AOA 914.999779
ARS 1144.91953
AUD 1.549775
AWG 1.8025
AZN 1.700839
BAM 1.72067
BBD 2.019048
BDT 121.496602
BGN 1.725145
BHD 0.377063
BIF 2933.5
BMD 1
BND 1.291083
BOB 6.910295
BRL 5.743497
BSD 1.000022
BTN 84.710644
BWP 13.559277
BYN 3.27258
BYR 19600
BZD 2.008666
CAD 1.37984
CDF 2875.000258
CHF 0.818725
CLF 0.024633
CLP 945.279844
CNY 7.22535
CNH 7.219885
COP 4299
CRC 506.081869
CUC 1
CUP 26.5
CVE 97.401173
CZK 21.904972
DJF 177.719932
DKK 6.565285
DOP 58.899188
DZD 132.647881
EGP 50.635597
ERN 15
ETB 132.650326
EUR 0.879965
FJD 2.257405
FKP 0.748092
GBP 0.74958
GEL 2.754945
GGP 0.748092
GHS 13.37451
GIP 0.748092
GMD 70.999703
GNF 8660.537545
GTQ 7.693661
GYD 209.209328
HKD 7.76002
HNL 25.914885
HRK 6.643198
HTG 130.69969
HUF 355.774998
IDR 16483.3
ILS 3.58745
IMP 0.748092
INR 84.71555
IQD 1310
IRR 42112.503552
ISK 128.910306
JEP 0.748092
JMD 158.694409
JOD 0.709206
JPY 142.929497
KES 129.250117
KGS 87.450126
KHR 4003.290617
KMF 433.504011
KPW 899.977045
KRW 1393.605025
KWD 0.30657
KYD 0.8333
KZT 514.510701
LAK 21624.808084
LBP 89598.835086
LKR 299.390713
LRD 199.99736
LSL 18.289183
LTL 2.95274
LVL 0.60489
LYD 5.459024
MAD 9.216381
MDL 17.094491
MGA 4444.999818
MKD 54.205616
MMK 2099.476264
MNT 3576.208671
MOP 7.993577
MRU 39.616417
MUR 45.439888
MVR 15.410069
MWK 1733.996736
MXN 19.57925
MYR 4.239007
MZN 63.900677
NAD 18.29039
NGN 1608.769537
NIO 36.796424
NOK 10.303995
NPR 135.53703
NZD 1.674502
OMR 0.384985
PAB 1.000031
PEN 3.6544
PGK 4.029984
PHP 55.403044
PKR 281.368849
PLN 3.75845
PYG 7991.90604
QAR 3.645449
RON 4.505403
RSD 103.134417
RUB 80.61297
RWF 1436.521448
SAR 3.750732
SBD 8.350849
SCR 14.216357
SDG 600.497936
SEK 9.604165
SGD 1.291205
SHP 0.785843
SLE 22.730201
SLL 20969.483762
SOS 571.45371
SRD 36.819029
STD 20697.981008
SVC 8.749395
SYP 13001.645496
SZL 18.27948
THB 32.724992
TJS 10.374858
TMT 3.51
TND 2.996437
TOP 2.342101
TRY 38.641495
TTD 6.786178
TWD 30.392497
TZS 2690.99984
UAH 41.438877
UGX 3658.997933
UYU 41.868649
UZS 12924.999759
VES 88.61243
VND 25962.5
VUV 120.667614
WST 2.663993
XAF 577.139891
XAG 0.03064
XAU 0.000295
XCD 2.70255
XDR 0.718649
XOF 575.999561
XPF 104.929283
YER 244.4992
ZAR 18.217201
ZMK 9001.194181
ZMW 26.724384
ZWL 321.999592
  • RBGPF

    2.8600

    65.86

    +4.34%

  • SCS

    0.0800

    9.95

    +0.8%

  • BCC

    -0.4500

    87.03

    -0.52%

  • NGG

    0.3200

    72.62

    +0.44%

  • CMSD

    0.1240

    22.434

    +0.55%

  • CMSC

    0.1150

    22.175

    +0.52%

  • BP

    -0.1800

    28.22

    -0.64%

  • RIO

    0.1900

    59.99

    +0.32%

  • GSK

    -0.3550

    37.145

    -0.96%

  • RYCEF

    -0.2200

    10.17

    -2.16%

  • JRI

    -0.0100

    13.04

    -0.08%

  • BTI

    -0.0450

    44.515

    -0.1%

  • BCE

    -0.4550

    21.135

    -2.15%

  • RELX

    -0.0800

    54.85

    -0.15%

  • VOD

    -0.2300

    9.44

    -2.44%

  • AZN

    0.1400

    70.4

    +0.2%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: © POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

F.Brown--ThChM